The NxTAG Respiratory Pathogen Panel + SARS-CoV-2 (NxTAG RPP + SARS‑CoV‑2), developed for use on the NxTAG-Enabled MAGPIX® System, is a qualitative test for the detection of nucleic acids from multiple respiratory viruses and bacteria in nasopharyngeal swabs. The formulation of the assay is identical to NxTAG RPP, with the exception of the additional reagents required for the detection of SARS‑CoV‑2. No changes have been made to the existing NxTAG RPP reagents, reaction conditions, workflow, or software thresholds; therefore, the performance characteristics of NxTAG RPP are still applicable to NxTAG RPP + SARS‑CoV‑2. Request Information
• Comprehensive Testing: Detects 19 viral pathogens, including SARS‑CoV‑2, and 2 bacterial pathogens in a single well, enabling thorough respiratory health analysis.
• Scalable Throughput: Process up to 96 samples in less than 3 hours post-extraction, accommodating variable, day-to-day testing demand.
• Minimal Hands-On Time: Pre-plated, lyophilized reagents facilitate a simple workflow with just one pipetting step, ensuring an easy fit in any lab’s daily routine. Request Information